1. In Vivo

Smart Immune’s Path To Unlocking The Underappreciated Thymus

ProTcells Can Be Differentiated In Just Seven Days

 
• By Chloe Kent

French-founded biotech Smart Immune has made significant headway in stimulating the thymus, a small gland with a huge immunological impact which rarely finds itself as a key clinical target. The company is now investigating the impact that two of its ProTcell products in patients with severe combined immunodeficiency and leukemia could have.

Depiction of the thymus
The thymus produces all of the T-cells a person will need before they've even hit puberty • Source: 1200

“The thymus is absolutely instrumental in arming your T-cells to fight viruses and cancers,” said Smart Immune CEO Karine Rossignol. “If they don’t go into the thymus to be educated, they’re not efficient to protect you from cancers and infections. We have created this company to fight against both.”

An often-overlooked aspect of the lymphatic system, the thymus gland sits in the chest between the lungs and makes T-cells....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from New Science

More from In Vivo

Wide Of The Mark: ‘The Worst EU Medtech Predictions Have Not Come True’

 
• By Ashley Yeo

Jana Grieb, European regulatory and market access legal expert at McDermott Will & Emery, explains why the healthtech and pharma industries are warming to the new EU health commissioner as he faces calls to make the MDR more “user friendly.”

This Belgian Biotech’s Drug Cocktail Could Help Reverse Muscle Aging

 
• By Jo Shorthouse

While big pharma pours billions into creating new anti-aging molecules, a Belgian startup has taken a different path: combining existing safe drugs with AI precision. The early results suggest it might be onto something revolutionary.

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By Jo Shorthouse

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy